Regeneron Pharmaceuticals (NASDAQ:REGN) PT Lowered to $1,050.00 at Wells Fargo & Company
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target decreased by Wells Fargo & Company from $1,200.00 to $1,050.00 in a research note issued on Tuesday, Benzinga reports. The firm presently has an “overweight” rating on the biopharmaceutical company’s stock. Wells Fargo & Company‘s price objective would suggest a potential upside of 9.11% […]
More Stories
JasmyCoin (JASMY) Self Reported Market Cap Reaches $938.64 Million
JasmyCoin (JASMY) traded 4.9% lower against the US dollar during the one day period ending at 0:00 AM Eastern on...
dForce USD Self Reported Market Cap Hits $14.53 Million (USX)
dForce USD (USX) traded down 0% against the dollar during the 1-day period ending at 0:00 AM Eastern on October...
ETHPoW (ETHW) Trading 0.7% Higher Over Last Week
ETHPoW (ETHW) traded 0.9% lower against the US dollar during the 24 hour period ending at 0:00 AM ET on...
Polymesh (POLYX) Price Hits $0.25 on Exchanges
Polymesh (POLYX) traded 3.5% lower against the U.S. dollar during the twenty-four hour period ending at 0:00 AM Eastern on...
HI Trading 0.1% Higher Over Last Week (HI)
HI (HI) traded up 0.3% against the U.S. dollar during the 1-day period ending at 0:00 AM ET on October...
Ryohin Keikaku (OTCMKTS:RYKKY) Stock Price Up 0.2% – Time to Buy?
Ryohin Keikaku Co., Ltd. (OTCMKTS:RYKKY – Get Free Report)’s share price was up 0.2% during mid-day trading on Tuesday ....